Pier Capital, LLC Coherus Bio Sciences, Inc. Transaction History

Pier Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$16.3 - $23.37 $5.6 Million - $8.02 Million	-343,308 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$13.1 - $22.1 $2.39 Million - $4.03 Million	-182,540 Reduced 34.71%	343,308 $7.59 Million
Q1 2019 Apr 24, 2019	SELL	$8.38 - $15.5 $685,048 - $1.27 Million	-81,748 Reduced 13.45%	525,848 $7.17 Million
Q4 2018 Feb 13, 2019	SELL	$8.65 - $16.28 $252,130 - $474,529	-29,148 Reduced 4.58%	607,596 $5.5 Million
Q3 2018 Nov 14, 2018	BUY	$14.45 - $20.25 $5.56 Million - $7.79 Million	384,501 Added 152.43%	636,744 $10.5 Million
Q2 2018 Aug 08, 2018	BUY	$10.25 - $17.45 $2.59 Million - $4.4 Million	252,243 New	252,243 $3.53 Million

135

77.9M

40.7K

50.1K

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $118M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

Get notified when there are updates to the investment portfolio of Pier Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Pier Capital, LLC with notifications on news.